[{"data":1,"prerenderedAt":272},["ShallowReactive",2],{"story-5349-tw":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":48,"questions":49,"relatedArticles":59,"body_color":270,"card_color":271},"5349",null,"三星生物製劑以策略性美國擴張，打破全球製藥製造界限","透過有針對性的跨境製造業投資，革新國際藥品供應鏈",[],[10,11,12,13,14,15,16,17,18,19,20,21,15,22,23,24,25,26,26,26,27,26,17,28,29,26,30,31,32,23,33,34,35,36,37,38,39,40,26,41,42,43,44,45,46,47],"https://commercialobserver.com/wp-content/uploads/sites/3/2025/12/John-Rim-HGSI-Samsung-Biologics-campus-Rockville-Md-credit-Samsung-Biologics.jpg?quality=80&w=763&h=489&crop=1","https://cdn.techinasia.com/wp-content/uploads/2025/06/1750134121_headquarters_itm1-750x419.jpg","https://image.ajunews.com/content/image/2025/12/22/20251222094433938159.jpg","https://www.biospectrumasia.com/uploads/articles/screenshot_22_12_2025_12138_www_prnewswire_com-27025.jpeg","https://www.koreabiomed.com/news/photo/202512/30050_32264_1016.jpg","https://cdn.zonebourse.com/static/resize/0/0//images/reuters/2025-04/2025-04-30T061040Z_1_LYNXMPEL3T07L_RTROPTP_4_GSK-RESULTS.JPG","https://koreajoongangdaily.joins.com/data/photo/2025/12/22/3da1e453-007e-4471-ae2a-0dd56ae6b89f.jpg","https://www.chosun.com/resizer/v2/MVTDMMTCGA4TOOJYGVRGKNJVHE.jpg?auth=c53c397423e1368d2bd9599b10640d6ff7e5b7ed0e9843acf424a64ebd6a715c&width=616","https://cdn.zonebourse.com/static/resize/1200/675//images/reuters/2024-10-09T081107Z_1_LYNXMPEK98083_RTROPTP_3_GERMANY.JPG","https://wimg.mk.co.kr/news/cms/202512/23/20251223_01110105000003_M00.jpg","https://www.globalbankingandfinance.com/_next/image/?url=https%3A%2F%2Fimagedelivery.net%2FMkQ8HKvpw9EqULcU_pSqWg%2Fcloud-bccb4c31-c889-45a7-ae13-69de0e2045aa%2Fpublic&w=3840&q=85&dpl=dpl_AW2uQ8ma8YWXu6MmDoKdviVr2XKJ","https://businessfacilities.com/wp-content/uploads/2025/12/samsung-biologics-gsk-md.jpg","https://newsimg.koreatimes.co.kr/2025/12/22/de376285-e78f-4d0b-9f63-c1bb9f1cbd57.jpg","https://wimg.heraldcorp.com/news/cms/2025/12/22/news-p.v1.20251222.ac0ef926fe1d4024bd06c43bf9aae125_P1.png","https://www.geneonline.com/wp-content/uploads/EN_Mobile_Dec_HIV_AIDS-450x350.png","https://bl-i.thgim.com/public/incoming/l6m6g2/article70424971.ece/alternates/LANDSCAPE_1200/f9c7e60d7c6e4e8e8507caae03a8eeef_thumb.jpg","https://mma.prnewswire.com/media/2850103/Image__Samsung_Biologics_Expands_U_S__Manufacturing_Capabilities.jpg","https://www.asiabusinessoutlook.com/uploaded_images/newstransfer/d7i01736220811_shutterstock_1668796654-scaled.jpg","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1SN2cq.img?w=768&h=512&m=6","https://www.azernews.az/media/2025/12/22/samsung_biologics.jpg","https://cdn.bisnow.net/fit?height=1200&type=png&url=https%3A%2F%2Fs3.amazonaws.com%2Fcdn.bisnow.net%2Fcontent%2Fimages%2F2025%2F12%2F69495ffa1d4ba-screenshot-2025-12-22-at-10-12-06-am.png&width=1200&sign=WbFuNxaEu_VAnVSDoyLPlGnrcmoBTZOIrtF9jbW4fbQ","https://wimg.mk.co.kr/news/cms/202512/22/news-p.v1.20251222.57dd4c90002044bd87368891bf9bcb2e_P1.jpg","https://etimg.etb2bimg.com/photo/126113611.cms","https://cdn4.premiumread.com/?url=https://www.manilatimes.net/theme_manilatimes/images/TMT_1920x1008.jpg&w=1200&q=100&f=webp&t=1","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2215021361.jpg?VersionId=UngKaoH_bkUnG.FBzEAB0.I9J9Tbdqj9","https://www.indianpharmapost.com/public/thumbs/news/2025/12/18647/Human_Genome_Sciences1.jpg","https://www.contractpharma.com/wp-content/uploads/sites/6/2025/12/human-genome-sciences.jpg","https://wimg.mk.co.kr/news/cms/202512/22/news-p.v1.20251222.439cb83c6cfa4c8cbd276b97b3b33b51_P1.jpg","https://unn.ua/_next/image?url=https%3A%2F%2Funn.ua%2Fimg%2F2025%2F12%2F22%2F1766362912-1073-large.webp&w=720&q=75","https://etimg.etb2bimg.com/thumb/msid-126112253,width-1200,height-900,resizemode-4/.jpg","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1SN8Zv.img?w=768&h=576&m=6","https://biz.chosun.com/resizer/v2/LNKJ7S73BFAHHGXFOUY34V7MVU.jpg?auth=a73c11558caf24315412a05b15d5e805285a246762d49095380da17e57b1a8f0&width=1200&height=630&smart=true","https://media.bizj.us/view/img/13113056/imagesamsungbiologicsexpandsusmanufacturingcapabilities*900xx2161-1218-0-0.jpg","http://koreabizwire.com/wp/wp-content/uploads/2025/01/AEN20250114002800320_01_i_org.jpg","https://www.reuters.com/resizer/v2/OPPP273TMJKEFBIK4LWZSRVDUA.jpg?auth=f3ee02bcc19483ffdf09c5351693428ccf1859c3e5360433c0d23a659c148aa9&width=1920&quality=80","https://m.economictimes.com/thumb/msid-126112281,width-1200,height-900,resizemode-4,imgsize-23350/samsung-biologics-to-invest-usd-4-8-billion-in-new-songdo-bio-campus.jpg","https://cdn.sanity.io/images/0vv8moc6/pharma_commerce/3a9baad4cf5d395b09197012b1369b904b38f795-1592x886.png?w=1592&max-h=886&fit=crop&auto=format","https://images.ft.com/v3/image/raw/https%3A%2F%2Fcms-image-bucket-productionv3-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com%2Fimages%2F3%2F8%2F2%2F8%2F11858283-2-eng-GB%2Fa9ad3878cab7-2025-12-17T000129Z_372490497_RC2AYCAK1RN4_RTRMADP_3_HEALTH-USA-GSK-2-.JPG?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto","**三星生物製劑**透過一項大膽的 2.8 億美元策略性收購，正在改寫國際製藥製造的規則，從而改變其全球生產能力。透過收購葛蘭素史克 (GSK) 位於美國馬里蘭州羅克維爾的工廠，該公司正在執行一項精密的市場進入策略，遠遠超出了單純的資產收購。\n\n此次收購不僅僅是一筆交易，更是一項經過深思熟慮的地緣政治和經濟策略。**三星生物製劑**正在建立一個雙半球生產系統，將韓國松島和美國羅克維爾連接起來，此舉在策略上緩解了區域供應鏈風險，同時為北美客戶提供了本地製造選擇。鑑於當前製藥本地化和潛在貿易政策轉變的格局，此舉尤其精明。\n\n這個 **6 萬公升的藥物生產設施** 具有關鍵優勢：500 名現有員工確保了即時的生產連續性和深厚的機構知識轉移。透過留用整個勞動力，三星生物製劑展現了一種細緻入微的理解，即成功的國際擴張不僅僅是基礎設施，更關乎人力資本和專業知識。\n\n至關重要的是，這項投資符合美國更廣泛的政策趨勢，強調國內製藥製造。根據現有的貿易協定，美國進口韓國藥品的關稅上限為 15%，而學名藥則享有免關稅待遇，這為這項策略性舉措創造了有利的環境。該公司目前在韓國的五個工廠的產能為 785,000 公升，這使得這個美國工廠成為補充而非多餘的擴張。\n\n此次收購表明了全球市場定位的精明方法。三星生物製劑不僅僅是購買一個設施，它正在競爭激烈的美國製藥製造領域建立橋頭堡。透過投資現有基礎設施，該公司可以快速擴大規模，而無需從頭開始建設，耗費時間。\n\n對於製藥公司和投資者而言，這代表了一場策略性國際擴張的大師課——利用現有資產、保持勞動力連續性，並為未來的市場動態做好準備。",[50,53,56],{"title":51,"answer":52,"author":5,"avatar":5,"time":5},"三星生物製劑公司為何要在美國製造廠投資 2.8 億美元？","三星生物製劑公司正透過建立美國生產基地，策略性地擴展其全球製造版圖。此舉使其能降低供應鏈風險，為北美客戶提供在地生產選擇，並可能受益於美國支持國內製藥生產的政策。",{"title":54,"answer":55,"author":5,"avatar":5,"time":5},"此次收購為三星生物製劑帶來哪些競爭優勢？","此次收購帶來多重優勢：即時擁有6萬公升的生產能力，留用500名經驗豐富的員工，潛在的關稅優惠，以及位於重要生技聚落的策略性地點。同時，也無需從頭建廠，即可快速進入市場。",{"title":57,"answer":58,"author":5,"avatar":5,"time":5},"這次收購如何融入三星生物製劑更廣泛的全球策略？","這代表三星生物製劑全球擴張策略的關鍵部分，建立連結韓國與美國的雙半球生產系統。這展現了該公司致力成為主要的國際合同生產組織（CMO）的決心，並擁有靈活、高品質的製藥生產能力。",[60,65,70,74,78,82,86,90,94,98,101,105,109,112,116,120,123,127,131,135,138,141,145,148,152,156,160,163,167,171,175,179,183,187,190,194,198,201,204,207,211,215,219,223,227,231,234,238,242,245,249,252,256,259,262,266],{"id":61,"title":62,"source":63,"logo":44,"time":64},129682,"Samsung Biologics to buy US drug production facility from GSK for $280 million","https://www.reuters.com/business/healthcare-pharmaceuticals/samsung-biologics-buy-us-drug-production-facility-gsk-280-mln-2025-12-21/","3天前",{"id":66,"title":67,"source":68,"logo":30,"time":69},132212,"Samsung Biologics To Pay $280M For Maryland Manufacturing Campus","https://www.bisnow.com/washington-dc/news/life-sciences/samsung-biologics-pays-280m-for-montgomery-county-manufacturing-campus-132479","2天前",{"id":71,"title":72,"source":73,"logo":31,"time":64},129683,"Samsung Biologics has taken over the U.S. biopharmaceutical production facility of global pharmaceut..","https://www.mk.co.kr/en/it/11497617",{"id":75,"title":76,"source":77,"logo":46,"time":69},132211,"Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition","https://www.pharmaceuticalcommerce.com/view/samsung-biologics-enters-us-manufacturing-market-gsk-site-acquisition",{"id":79,"title":80,"source":81,"logo":5,"time":64},129684,"Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK","https://www.prnewswire.com/news-releases/samsung-biologics-expands-us-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk-302647637.html",{"id":83,"title":84,"source":85,"logo":10,"time":69},132210,"Samsung Biologics to Acquire First U.S. Drug Manufacturing Facility in $280M Deal","https://commercialobserver.com/2025/12/samsung-biologics-maryland-life-sciences/",{"id":87,"title":88,"source":89,"logo":14,"time":64},129600,"Samsung Biologics secures 1st US manufacturing base with GSK facility acquisition","https://www.koreabiomed.com/news/articleView.html?idxno=30050",{"id":91,"title":92,"source":93,"logo":35,"time":64},132214,"Samsung Biologics strengthens U.S. presence with acquisition of GSK’s Human Genome Sciences or $280 million","https://www.indianpharmapost.com/biopharma/samsung-biologics-strengthens-us-presence-with-acquisition-of-gsks-human-genome-sciences-or-280-million-18647",{"id":95,"title":96,"source":97,"logo":17,"time":64},129601,"Samsung Biologics Acquires GSK's U.S. Facility, First Production Base","https://www.chosun.com/english/industry-en/2025/12/22/KQ3YOEEQLZB27KW46B4EYRILDA/",{"id":99,"title":62,"source":100,"logo":33,"time":69},132213,"https://www.manilatimes.net/2025/12/23/business/foreign-business/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/2248220",{"id":102,"title":103,"source":104,"logo":22,"time":64},129681,"Samsung Biologics takes over bio plant in Maryland from GSK","https://www.koreatimes.co.kr/business/tech-science/20251222/samsung-biologics-takes-over-bio-plant-in-maryland-from-gsk",{"id":106,"title":107,"source":108,"logo":11,"time":64},129594,"Samsung Biologics to buy US drug plant from GSK for $280m","https://www.techinasia.com/news/samsung-biologics-buy-us-drug-plant-gsk-280m",{"id":110,"title":62,"source":111,"logo":45,"time":64},129595,"https://m.economictimes.com/news/international/business/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/articleshow/126112276.cms",{"id":113,"title":114,"source":115,"logo":39,"time":64},129596,"Samsung Biologics to buy its first US drug production facility from GSK for $280 million","https://pharma.economictimes.indiatimes.com/news/pharma-industry/samsung-biologics-to-buy-its-first-us-drug-production-facility-from-gsk-for-280-million/126112253",{"id":117,"title":118,"source":119,"logo":5,"time":64},129597,"Samsung Biologics acquires Human Genome Sciences from GSK","https://www.tipranks.com/news/the-fly/samsung-biologics-acquires-human-genome-sciences-from-gsk-thefly",{"id":121,"title":80,"source":122,"logo":26,"time":64},129598,"https://themalaysianreserve.com/2025/12/22/samsung-biologics-expands-u-s-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk/",{"id":124,"title":125,"source":126,"logo":26,"time":64},129599,"Samsung Biologics Expands U.S. Manufacturing Capabilities with S","https://www.gurufocus.com/news/4079138/samsung-biologics-expands-us-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk",{"id":128,"title":129,"source":130,"logo":43,"time":64},129590,"Samsung Biologics to Buy GSK Manufacturing Facility in U.S. for $280 Million","http://koreabizwire.com/samsung-biologics-to-buy-gsk-manufacturing-facility-in-u-s-for-280-million/340629",{"id":132,"title":133,"source":134,"logo":27,"time":64},129591,"Samsung Biologics to Acquire GSK's Maryland Plant for $280M","https://www.asiabusinessoutlook.com/news/samsung-biologics-to-acquire-gsk-s-maryland-plant-for-280m-nwid-10922.html",{"id":136,"title":62,"source":137,"logo":32,"time":64},129592,"https://manufacturing.economictimes.indiatimes.com/news/life-sciences/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/126113585",{"id":139,"title":62,"source":140,"logo":40,"time":64},129593,"https://www.msn.com/en-in/money/topstories/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/ar-AA1SNhV3?ocid=finance-verthp-feeds",{"id":142,"title":143,"source":144,"logo":34,"time":64},130809,"Samsung Biologics pays GSK $280M to secure first US manufacturing site","https://www.fiercepharma.com/manufacturing/samsung-biologics-pays-gsk-280m-secure-first-us-manufacturing-site",{"id":146,"title":114,"source":147,"logo":20,"time":64},129583,"https://www.globalbankingandfinance.com/samsung-biologics-usa/",{"id":149,"title":150,"source":151,"logo":23,"time":64},129584,"Samsung Biologics acquires $280m GSK plant, securing first US manufacturing base","https://www.theinvestor.co.kr/article/10641706",{"id":153,"title":154,"source":155,"logo":5,"time":64},129585,"Samsung Biologics Stock: Slips Nearly 5% After $280M GSK Maryland Plant Acquisition","https://coincentral.com/samsung-biologics-stock-slips-nearly-5-after-280m-gsk-maryland-plant-acquisition/",{"id":157,"title":158,"source":159,"logo":13,"time":64},129586,"Korea's Samsung Biologics expands US manufacturing capabilities after acquiring Human Genome Sciences from GSK","https://www.biospectrumasia.com/news/28/27025/koreas-samsung-biologics-expands-us-manufacturing-capabilities-after-acquiring-human-genome-sciences-from-gsk.html",{"id":161,"title":62,"source":162,"logo":25,"time":64},129587,"https://www.thehindubusinessline.com/companies/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/article70424941.ece",{"id":164,"title":165,"source":166,"logo":5,"time":64},129588,"Samsung Biologics Unit to Acquire GSK's Human Genome Sciences Facility in US for $280 Million","https://www.marketscreener.com/news/samsung-biologics-unit-to-acquire-gsk-s-human-genome-sciences-facility-in-us-for-280-million-ce7d50d2da8cfe24",{"id":168,"title":169,"source":170,"logo":16,"time":64},129589,"Samsung Biologics to acquire U.S. drug manufacturing facility from GSK","https://koreajoongangdaily.joins.com/news/2025-12-22/business/industry/Samsung-Biologics-to-acquire-US-drug-manufacturing-facility-from-GSK/2483446",{"id":172,"title":173,"source":174,"logo":5,"time":64},130778,"GSK to Sell US Manufacturing Site to Samsung Biologics for $280 Million","https://www.marketscreener.com/news/gsk-to-sell-us-manufacturing-site-to-samsung-biologics-for-280-million-ce7d50d2df8ef62c",{"id":176,"title":177,"source":178,"logo":37,"time":64},130779,"Samsung Biologics has secured a production base in North America by acquiring the U.S. biopharmaceut..","https://www.mk.co.kr/en/it/11504576",{"id":180,"title":181,"source":182,"logo":38,"time":64},129580,"Samsung Biologics acquires its first US plant for $280 million","https://unn.ua/en/news/samsung-biologics-acquires-its-first-us-plant-for-dollar280-million",{"id":184,"title":185,"source":186,"logo":18,"time":64},129581,"GSK to Sell Human Genome Sciences Unit to Samsung Biologics for $280 Million","https://www.marketscreener.com/news/gsk-to-sell-human-genome-sciences-unit-to-samsung-biologics-for-280-million-ce7d50d2df88fe27",{"id":188,"title":177,"source":189,"logo":19,"time":64},129582,"https://www.mk.co.kr/en/it/11504495",{"id":191,"title":192,"source":193,"logo":29,"time":69},130781,"Samsung Biologics to acquire GSK’s US plant","https://www.azernews.az/region/251990.html",{"id":195,"title":196,"source":197,"logo":17,"time":69},130782,"Samsung Biologics Acquires GlaxoSmithKline's U.S. Biopharmaceutical Facility","https://www.chosun.com/english/industry-en/2025/12/23/NSIRQV3NKZAE3IRMSPVDUDHFYE/",{"id":199,"title":150,"source":200,"logo":23,"time":64},130780,"https://www.koreaherald.com/article/10641494",{"id":202,"title":62,"source":203,"logo":5,"time":64},130785,"https://www.pharmalive.com/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/",{"id":205,"title":62,"source":206,"logo":15,"time":64},130786,"https://www.marketscreener.com/news/samsung-biologics-to-buy-its-first-us-drug-production-facility-from-gsk-for-280-million-ce7d50d2db8df322",{"id":208,"title":209,"source":210,"logo":12,"time":64},129578,"Samsung Biologics acquires GSK biopharmaceutical plant in U.S. for $280 million","https://www.ajupress.com/view/20251222093600641",{"id":212,"title":213,"source":214,"logo":47,"time":64},130783,"Samsung Biologics to buy GSK drug plant in US for $280m","https://asia.nikkei.com/business/business-deals/samsung-biologics-to-buy-gsk-drug-plant-in-us-for-280m",{"id":216,"title":217,"source":218,"logo":5,"time":64},129579,"Samsung Biologics acquires first U.S.-based manufacturing facility","https://en.yna.co.kr/view/AEN20251222002500320",{"id":220,"title":221,"source":222,"logo":36,"time":64},130784,"Samsung Biologics Acquires Human Genome Sciences from GSK","https://www.contractpharma.com/breaking-news/samsung-biologics-acquires-human-genome-sciences-from-gsk/",{"id":224,"title":225,"source":226,"logo":24,"time":69},132209,"Samsung Biologics Acquires $280 Million Manufacturing Facility in Maryland from GSK","https://www.geneonline.com/samsung-biologics-acquires-280-million-manufacturing-facility-in-maryland-from-gsk/",{"id":228,"title":229,"source":230,"logo":21,"time":69},132208,"Samsung Biologics Pays $280M For U.S. Drug Manufacturing Facility| Biotech","https://businessfacilities.com/samsung-biologics-pays-280m-maryland-drug-manufacturing-facility",{"id":232,"title":80,"source":233,"logo":26,"time":64},130787,"https://www.streetinsider.com/PRNewswire/Samsung+Biologics+Expands+U.S.+Manufacturing+Capabilities+with+Strategic+Acquisition+of+Human+Genome+Sciences+from+GSK/25766508.html",{"id":235,"title":236,"source":237,"logo":5,"time":69},132207,"News | Samsung Biologics to acquire facility outside DC for first US manufacturing plant","https://www.costar.com/article/2043707008/samsung-biologics-to-acquire-facility-outside-dc-for-first-us-manufacturing-plant",{"id":239,"title":240,"source":241,"logo":41,"time":64},129602,"Samsung Biologics acquires Rockville plant to secure US manufacturing base - CHOSUNBIZ","https://biz.chosun.com/en/en-science/2025/12/22/ORU4DPSYPBB37DX7RANLGIRT3A/",{"id":243,"title":62,"source":244,"logo":28,"time":64},129603,"https://www.msn.com/en-us/money/companies/samsung-biologics-to-buy-us-drug-production-facility-from-gsk-for-280-million/ar-AA1SMM0P?ocid=finance-verthp-feeds",{"id":246,"title":247,"source":248,"logo":15,"time":64},129604,"Samsung Biologics to buy U.S. drug production facility from GSK for $280 million","https://www.marketscreener.com/news/samsung-biologics-to-buy-u-s-drug-production-facility-from-gsk-for-280-mln-ce7d50d2db8df722",{"id":250,"title":80,"source":251,"logo":26,"time":64},129605,"https://www.lelezard.com/en/news-22060311.html",{"id":253,"title":254,"source":255,"logo":5,"time":64},129606,"Samsung Biologics snaps up Maryland drug plant, its first in the US","https://www.stocktitan.net/news/GSK/samsung-biologics-expands-u-s-manufacturing-capabilities-with-58iknggvxlzv.html",{"id":257,"title":80,"source":258,"logo":26,"time":64},129607,"https://www.barchart.com/story/news/36736421/samsung-biologics-expands-u-s-manufacturing-capabilities-with-strategic-acquisition-of-human-genome-sciences-from-gsk",{"id":260,"title":80,"source":261,"logo":5,"time":64},129608,"https://finance.yahoo.com/news/samsung-biologics-expands-u-manufacturing-224300355.html",{"id":263,"title":264,"source":265,"logo":26,"time":64},129609,"Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK – Company Announcement - FT.com","https://markets.ft.com/data/announce/detail?dockey=600-202512211743PR_NEWS_USPRX____CN52272-1",{"id":267,"title":268,"source":269,"logo":42,"time":64},132370,"Samsung Biologics to acquire GSK's Rockville campus for $280M in first US manufacturing move","https://www.bizjournals.com/washington/news/2025/12/22/samsung-biologics-gsk-acquisition-rockville.html","#779d56ff","#779d564d",1766645457453]